Zhou T, Wang Y, Zhao X, Liu Y, Wang YX, Gang XK, Wang GX. Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review. World J Clin Cases 2019; 7(10): 1213-1220 [PMID: 31183355 DOI: 10.12998/wjcc.v7.i10.1213]
Corresponding Author of This Article
Gui-Xia Wang, MD, PhD, Professor, Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Jilin University, 71 Xinmin Street, Changchun 130021, Jilin Province, China. gwang168@jlu.edu.cn
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. May 26, 2019; 7(10): 1213-1220 Published online May 26, 2019. doi: 10.12998/wjcc.v7.i10.1213
Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
Tong Zhou, Yao Wang, Xue Zhao, Yang Liu, Ying-Xuan Wang, Xiao-Kun Gang, Gui-Xia Wang
Tong Zhou, Xue Zhao, Ying-Xuan Wang, Xiao-Kun Gang, Gui-Xia Wang, Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Jilin University, Changchun 130021, Jilin Province, China
Yao Wang, Department of Orthopedics, The Second Hospital of Jilin University, Jilin University, Changchun 130041, Jilin Province, China
Yang Liu, Department One of The Health Careful VIP, Jilin Provincial People's Hospital, Changchun 130000, Jilin Province, China
Author contributions: Zhou T, Wang GX and Gang XK conceived the study; Wang Y, Liu Y and Wang YX collected the human documents; Zhou T, Gang XK and Zhao X wrote the paper.
Supported byDevelopment and Reform Commission Jilin Province, NO. 2017C019; and Science and Technology Agency of Jilin Province, No. 20170623092TC-01 and No. 20180623083TC-01.
Informed consent statement: Informed consent was obtained from patients regarding the use of specimens for case report.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The guidelines of the CARE Checklist (2016) have been adopted.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Gui-Xia Wang, MD, PhD, Professor, Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Jilin University, 71 Xinmin Street, Changchun 130021, Jilin Province, China. gwang168@jlu.edu.cn
Telephone: +86-431-88782557 Fax: +86-431-88782557
Received: January 24, 2019 Peer-review started: January 25, 2019 First decision: March 9, 2019 Revised: March 17, 2019 Accepted: March 26, 2019 Article in press: March 26, 2019 Published online: May 26, 2019 Processing time: 123 Days and 1.9 Hours
Core Tip
Core tip: Small-cell lung cancer (SCLC) is a fatal tumor that is increasing in prevalence. Prognosis of patients with SCLC is closely related to early diagnosis. We report two middle-aged patients who were originally diagnosed with diabetes mellitus with no classical symptoms of lung cancer. Ectopic adrenocorticotropic hormone syndrome symptoms including thyroid dysfunction, hypercortisolism, and glucose intolerance, which are related to elevated adrenocorticotropic hormone and cortisol levels, were all normal after anticancer treatment. Our findings highlight that SCLC might start with diabetes mellitus and increased cortisol level and hypokalemia or other ectopic adrenocorticotropic hormone syndrome symptoms, and it reminds clinicians of the importance of early diagnosis of SCLC with ectopic adrenocorticotropic hormone syndrome.
